Past performance does not predict future results. Informational only, not investment advice.
Linde is a reasonable compounder but the author views it as overvalued, particularly given its dependence on AI capex spending and financial engineering in earnings growth. The stock may struggle in a rising rate environment and is currently under pressure from market sentiment.
Mission-critical industrial and medical gases and engineering services provider with global footprint. Positioned to benefit from secular tailwinds including AI infrastructure, clean energy transition, and aging population healthcare demands.
Linde is positioned to benefit from two major trends: rocket/space industry demand for liquid oxygen and nitrogen (especially SpaceX Starbase), and emerging hydrogen-powered AI data centers requiring liquid hydrogen for power and cooling. With a strong industrial gas foundation and near all-time highs, the stock has upside if recognized alongside upcoming space and AI market events.
End of results.